94
Participants
Start Date
February 9, 2017
Primary Completion Date
January 1, 2021
Study Completion Date
December 14, 2022
Pembrolizumab
200 mg of study drug is given through intravenous (IV) administration once every 21 days for 3 months.
Brachytherapy
Radiation is done for standard clinical care purposes.
Cisplatin
40 mg of chemotherapy drug will be given weekly for 5-6 weeks.
Johns Hopkins, Baltimore
INOVA Fairfax Hospital, Falls Church
University of Virginia, Charlottesville
Virginia Commonwealth University, Richmond
Levine Cancer Institute, Charlotte
University of South Alabama Mitchell Cancer Institute, Mobile
Washington University, School of Medicine, St Louis
University of Oklahoma, Oklahoma City
Merck Sharp & Dohme LLC
INDUSTRY
Linda R Duska
OTHER